February 20, 2025 - 18:57

A new bill in the California Senate aims to empower residents in their battles against health insurance companies that deny necessary care. Introduced by Senator Scott Wiener (D-San Francisco), Senate Bill 363 seeks to impose significant financial penalties on insurers that refuse to provide coverage for medically necessary treatments. Under this proposed legislation, health insurers could face fines of up to $1 million for unjustly denying care to patients.
The bill reflects growing frustration among Californians who have experienced firsthand the challenges of navigating insurance claims and the often opaque decision-making processes of health insurers. Advocates argue that the measure could serve as a powerful deterrent against arbitrary denials and encourage insurers to prioritize patient care over profit margins.
Supporters of the bill believe it could lead to more equitable healthcare access, ensuring that individuals receive the treatments they need without the fear of financial repercussions. As the bill progresses through the legislative process, it has the potential to reshape how health insurance companies operate in California.
July 2, 2026 - 04:03
VA health secretary quits less than a year into tenureJohn Bartrum, the official who oversaw the Veterans Health Administration`s troubled rollout of a new electronic health records system, has resigned from his post less than a year after taking the...
July 1, 2026 - 08:37
Anglia Ruskin mental health nursing course under reviewThe Nursing and Midwifery Council has called for an `extraordinary review` of the mental health nursing course at Anglia Ruskin University. The regulatory body`s decision comes amid concerns over...
June 30, 2026 - 22:44
Politics: High Cost Of Healthcare And The Political FalloutAmericans are feeling the squeeze of rising healthcare expenses like never before. For the first time in five years, fewer than half of U.S. adults say they can consistently afford medical care,...
June 30, 2026 - 15:13
Top GLP-1 prescription indications include sleep apnea, depression and kidney disease, study findsA new analysis of insurance claims data reveals that prescriptions for GLP-1 medications are increasingly being approved for conditions far beyond their original use for diabetes and weight loss....